Mostrando 7 resultados de: 7
Subtipo de publicación
Article(7)
Publisher
Journal of Neural Transmission(2)
Bone(1)
Current Pharmaceutical Design(1)
Frontiers in Behavioral Neuroscience(1)
Pharmacology Biochemistry and Behavior(1)
Área temáticas
Farmacología y terapéutica(6)
Enfermedades(4)
Fisiología humana(4)
Temas específicos de historia natural de los animales(2)
Bioquímica(1)
Origen
scopus(7)
Chronic exposure to methylphenidate impairs appendicular bone quality in young rats
ArticleAbstract: Methylphenidate (MP) is a psychostimulant widely prescribed to treat Attention Deficit HyperactivityPalabras claves:Biomechanics, DXA, Growth suppression, methylphenidate, TestosteroneAutores:Ananth M., David Edward Komatsu, Hadjiargyrou M., Janda H.A., John C.M., Mary M.N., Robison L.S., Swanson J.M., Thanos P.K., Volkow N.D.Fuentes:scopusChronic oral methylphenidate treatment increases microglial activation in rats
ArticleAbstract: Methylphenidate (MP) is a widely prescribed psychostimulant used to treat attention deficit hyperactPalabras claves:Attention Deficit Hyperactivity Disorder, Autoradiography, inflammation, methylphenidate, Microglia, ritalinAutores:Carias E., David Edward Komatsu, Delis F., Eiden R., Hadjiargyrou M., Hamilton J., Quattrin T., Robison L.S., Thanos P.K.Fuentes:scopusChronic oral methylphenidate treatment reversibly increases striatal dopamine transporter and dopamine type 1 receptor binding in rats
ArticleAbstract: Previously, we created an 8-h limited-access dual bottle drinking paradigm to deliver methylphenidatPalabras claves:dopamine, methylphenidate, Psychostimulant, Reward deficiency syndrome, reward, addiction, TransporterAutores:Ananth M., David Edward Komatsu, Hadjiargyrou M., Robison L.S., Thanos P.K.Fuentes:scopusA pharmacokinetic model of oral methylphenidate in the rat and effects on behavior
ArticleAbstract: Most animal studies using methylphenidate (MP) do not administer it the same way it is administeredPalabras claves:Attention Deficit Hyperactivity Disorder, Dopamine transporter, methylphenidate, Psychostimulant, ritalinAutores:Cooper T., David Edward Komatsu, Hadjiargyrou M., Hwang Y., Robison L.S., Steier J., Swanson J.M., Thanos P.K., Volkow N.D.Fuentes:scopusAbstinence from Chronic Methylphenidate Exposure Modifies Cannabinoid Receptor 1 Levels in the Brain in a Dose-dependent Manner
ArticleAbstract: Introduction: Methylphenidate (MP) is a widely used psychostimulant prescribed for Attention DeficitPalabras claves:Attention Deficit Hyperactivity Disorder, Cannabinoid receptor 1, Endocannabinoid system, methylphenidate, Psychostimulant, ritalinAutores:Connor C., David Edward Komatsu, Hadjiargyrou M., Hamilton J., Robison L.S., Thanos P.K.Fuentes:scopusMethylphenidate regulation of osteoclasts in a dose- A nd sex-dependent manner adversely affects skeletal mechanical integrity
ArticleAbstract: Methylphenidate (MP) is the most prescribed psychostimulant for ADHD patients, with clinically demonPalabras claves:Autores:Chernoff E., David Edward Komatsu, Fricke D., Hadjiargyrou M., Robison L.S., Thanos P.K., Uddin S.M.Z.Fuentes:scopusSex differences in the physiological and behavioral effects of chronic oral methylphenidate treatment in rats
ArticleAbstract: Methylphenidate (MP) is a psychostimulant prescribed for Attention Deficit Hyperactivity Disorder. PPalabras claves:Attention Deficit Hyperactivity Disorder, methylphenidate, Psychostimulant, ritalin, Sensitization, Sex differencesAutores:David Edward Komatsu, Fricke D., Gandhi J., Hadjiargyrou M., Lam C., Lee J., Mauceri A., Miao E., Michaelos M., Paeng S., Robison L.S., Thanos P.K., Vitale M.Fuentes:scopus